List of works - Mark A Fiala

A phase I study of thymoglobulin for relapsed or refractory multiple myeloma

scientific article published on 19 June 2015

A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myeloma

scientific article published on 28 July 2014

African American patients may or may not have poorer response rates after monoclonal antibody treatment: Overreliance on P values in underpowered studies

scientific article published on 28 March 2019

Bendamustine, lenalidomide, and dexamethasone (BRD) is highly effective with durable responses in relapsed multiple myeloma.

scientific article published on 2 September 2015

Co-evolution of tumor and immune cells during progression of multiple myeloma

scientific article published on 07 May 2021

Deep sequencing reveals myeloma cells in peripheral blood in majority of multiple myeloma patients

scientific article published on 2 October 2013

Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor

scientific article published on 24 March 2015

Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome

scientific article

Maintenance therapy following salvage autologous stem cell transplant in patients with multiple myeloma

scientific article published on 28 August 2019

PI3KCA plays a major role in multiple myeloma and its inhibition with BYL719 decreases proliferation, synergizes with other therapies and overcomes stroma-induced resistance.

scientific article published on 9 January 2014

POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis

scientific article published in May 2022

Personalization of cancer treatment using predictive simulation

scientific article

Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML.

scientific article published on 2 February 2014

Re: Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma.

scientific article published on 11 March 2015

Socioeconomic status is independently associated with overall survival in patients with multiple myeloma

scientific article published on 4 February 2015

The characteristics and outcomes of patients with multiple myeloma dual refractory or intolerant to bortezomib and lenalidomide in the era of carfilzomib and pomalidomide.

scientific article published on 24 June 2013

VLA4-nanoparticles hijack cell adhesion mediated drug resistance (CAM-DR) to target refractory myeloma cells and prolong survival

scientific article published on 22 December 2020

List of works by Mark A Fiala